MedPath

TEVA TAKEDA PHARMA LTD.

TEVA TAKEDA PHARMA LTD. logo
🇯🇵Japan
Ownership
Subsidiary
Established
2016-04-01
Employees
101
Market Cap
-
Website
http://www.takeda-teva.com

Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"

Completed
Conditions
Multiple Sclerosis
Interventions
First Posted Date
2017-07-06
Last Posted Date
2024-06-13
Lead Sponsor
Teva Takeda Pharma Ltd.
Target Recruit Count
1332
Registration Number
NCT03209479
Locations
🇯🇵

Takeda selected site, Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath